BPC-157 is an experimental peptide, and it has not been approved by the FDA to diagnose, treat, cure, or prevent any disease
Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology
Androgenetic alopecia and prostate cancer: findings from an Australian case-control study
most plans do not require a diabetes GLP-1 trial before approving a weight-loss GLP-1
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase
Lipotropic Compounds (often included) - Methionine, Inositol, and Choline: These compounds help break down fat, support liver function, and prevent fat accumulation